# Gabapentin in Fibromyalgia Trial (GIFT)

> **NCT00057278** · PHASE2,PHASE3 · COMPLETED · sponsor: **National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)** · enrollment: 150 (—)

## Conditions studied

- Fibromyalgia

## Interventions

- **DRUG:** gabapentin

## Key facts

- **NCT ID:** NCT00057278
- **Lead sponsor:** National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
- **Sponsor class:** NIH
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-03
- **Primary completion:** —
- **Final completion:** 2006-01
- **Target enrollment:** 150 (—)
- **Last updated:** 2007-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00057278

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00057278, "Gabapentin in Fibromyalgia Trial (GIFT)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00057278. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*